This is an old revision of the document!
Global Antibiotic Research & Development Partnership
The Global Antibiotic Research & Development Partnership (GARDP) is a Swiss non-governmental organization based in Geneva, Switzerland. GARDP “engages in public and private sector partnerships to research and develop new drugs that fit public health needs.”1)
History
GARDP was founded in 2016 by the World Health Organization (WHO) and the Drugs for Neglected Diseases Initiative (DNDi).2)
Organization
Affiliations
| Name | Position | Notes |
|---|---|---|
| Marco Cavaleri | Expert3) | Head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA) |
REVIVE
GARDP launched REVIVE in January 2018 to promote the continued acceleration of antimicrobial resistance research and development.4) REVIVE co-organizes the Antimicrobial Chemotherapy Conference with the British Society for Antimicrobial Chemotherapy (BSAC). Additional partners include:
External links
1)
, 2)
About GARDP. (2022, September 27). GARDP. https://web.archive.org/web/20230308232337/https://gardp.org/about-gardp/
3)
Kouassi, V. Marco Cavaleri. REVIVE. Retrieved March 8, 2023, from https://web.archive.org/web/20230308225834/https://revive.gardp.org/marco-cavaleri/
4)
About the project. REVIVE. Retrieved October 5, 2022, from https://web.archive.org/web/20221005183025/https://revive.gardp.org/about-revive/#organisations-working-with-us